Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2021年3月2日
	新闻
	Finding Support When You Have a Rare Lung Cancer Healthline adenosquamous carcinoma of the lung; salivary gland-type lung carcinoma; lung carcinoids; granular cell lung tumors. Finding emotional and lifestyle ... 标记为不相关
	ACGT awards grant to advance strategies for treating lung cancer EurekAlert ... has been awarded $500,000 from Alliance for Cancer Gene Therapy (ACGT) to advance a promising immunotherapy approach to fight lung cancer ... 标记为不相关
	New robot at St. Joseph's/Candler could help catch lung cancer early WSAV-TV SAVANNAH, Ga. (WSAV) – Doctors at St. Joseph's/Candler say lung cancer patients have a better chance of survival thanks to new robotic technology ... 标记为不相关
	Lung cancer cells have differential signaling responses to KRAS inhibitor treatment EurekAlert In a new article published in Clinical Cancer Research, Moffitt Cancer Center researchers show that various subtypes of lung cancer cells activate ... 标记为不相关
	Lung cancer cells activate different signaling pathways in response to KRAS inhibitors News-Medical.net Genetic alterations of the KRAS gene are some of the most common mutations in lung cancer patients, but unfortunately these patients have few ... 标记为不相关
	Lung Cancer Cells Have Differential Signaling Responses to KRAS Inhibitor Treatment with ... Newswise Newswise — TAMPA, Fla. – Genetic alterations of the KRAS gene are some of the most common mutations in lung cancer patients, but unfortunately ... 标记为不相关
	(pembrolizumab) Indication in Metastatic Small Cell Lung Cancer in the US Business Wire ... indication for KEYTRUDA (pembrolizumab) for the treatment of patients with metastatic small cell lung cancer (SCLC) with disease progression on ... 标记为不相关
	Diagnostic and Therapeutic Applications of Exosome Nanovesicles in Lung Cancer: State-of-The-Art DocWire News Lung cancer is a malignant disease with a frequency of various morbidity, mortality, and poor prognosis in patients that the conventional therapeutic ... 标记为不相关
	Frontline Cemiplimab Monotherapy Improved Overall, Progression-Free Survival for High PD-L1 ... Cancer Network ... cemiplimab improved overall and progression-free survival for patients with advanced non–small cell lung cancer with PD-L1 of at least 50%. 标记为不相关
	Stereotactic body radiotherapy for synchronous early stage non-small cell lung cancer DocWire News INTRODUCTION: In patients with non-small cell lung cancer (NSCLC) who present with multiple pulmonary nodules, it is often difficult to distinguish ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈